P. Scholze et al., AFFINITY OF VARIOUS LIGANDS FOR GABA(A) RECEPTORS CONTAINING ALPHA(4)BETA(3)GAMMA(2), ALPHA(4)GAMMA(2), OR ALPHA(1)BETA(3)GAMMA(2) SUBUNITS, European journal of pharmacology, 304(1-3), 1996, pp. 155-162
The potency of 30 benzodiazepine binding site ligands from 14 differen
t structural classes for inhibition of [H-3]Ro 15-4513 zido-5,6-dihydr
o-5-methyl-6-oxo-4H-imidazo[1,5-a][ 1,4]benzodiazepine-3-carboxylate)
binding to human embryonic kidney (HEK) 293 cells transiently transfec
ted with alpha(4) beta(3) gamma(2S) or alpha(1) beta(3) gamma(2S) subu
nits of GABA(A) receptors was investigated. Most of these compounds we
re unable to significantly inhibit [H-3]Ro 15-4513 binding to alpha(4)
beta(3) gamma(2S) receptors under conditions where they potently inhi
bited binding to alpha(1) beta(3) gamma(2S) receptors. Nevertheless, c
ompounds from four different structural classes were identified which
exhibited a high affinity for alpha(4) beta(3) gamma(2S) receptors. Va
riation of the structure of these compounds could lead to new ligands
selectively interacting with alpha(4) beta(3) gamma(2S) receptors. Com
pounds interacting with alpha(4) beta(3) gamma(2S) receptors were also
able to inhibit [H-3]Ro 15-4513 binding to receptors consisting of al
pha(4) gamma(2S) subunits with comparable potency. These results suppo
rt the conclusion that the a subunit is a major determinant of the ben
zodiazepine binding site properties of GABA, receptors containing a an
d gamma subunits.